Search
Patexia Research
Case number 1:21-cv-01575

Bayer Healthcare LLC et al v. Aurobindo Pharma Ltd. et al > Documents

Date Field Doc. No.Description (Pages)
Aug 5, 2022 47 Stipulation and Order (2)
Docket Text: STIPULATION to Extend Time. Signed by Judge William C. Bryson on 8/5/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB (nmg)
Aug 5, 2022 46 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to advise the court as to disputed and undisputed claim construction issues and their proposed constructions for each of the identified issues, disputed and undisputed to August 9, 2022 - filed by Bayer Healthcare LLC. (Fahnestock, Derek)
Aug 1, 2022 45 SO ORDERED (3)
Docket Text: SO ORDERED, re (46 in 1:21-cv-01429-WCB, 44 in 1:21-cv-01770-WCB, 43 in 1:21-cv-01575-WCB) STIPULATION TO EXTEND TIME to submit a proposed protective order to August 12, 2022 filed by Apotex Inc., Apotex Corp. Signed by Judge William C. Bryson on 08/01/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB(smg)
Jul 29, 2022 44 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendants (Nos. 1-4) and (2) Plaintiffs' First Set of Requests for Production to Defendants (Nos. 1-51) filed by Bayer Healthcare LLC, Meda Pharmaceuticals Inc..(Fahnestock, Derek)
Jul 29, 2022 43 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to August 12, 2022 - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth)
Jul 11, 2022 42 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Production of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.)
Jul 8, 2022 38 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for submission of a proposed protective order to July 29, 2022 - filed by Bayer Healthcare LLC. (Fahnestock, Derek)
Jul 8, 2022 41 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Bayer Healthcare LLC's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery - filed by Bayer Healthcare LLC.(Fahnestock, Derek)
Jul 8, 2022 40 Notice (Other) (3)
Docket Text: NOTICE of Meda Pharmaceuticals Inc.'s Paragraph 3 Disclosures by Meda Pharmaceuticals Inc. (Ward, Jennifer)
Jul 8, 2022 39 SO ORDERED (3)
Docket Text: SO ORDERED, re (40 in 1:21-cv-01429-WCB, 38 in 1:21-cv-01575-WCB, 34 in 1:21-cv-01770-WCB) STIPULATION TO EXTEND TIME for submission of a proposed protective order to July 29, 2022 filed by Bayer Healthcare LLC. Signed by Judge William C. Bryson on 07/08/2022. Associated Cases: 1:21-cv-01575-WCB, 1:21-cv-01429-WCB, 1:21-cv-01770-WCB(smg)
Jul 1, 2022 37 SO ORDERED (3)
Docket Text: SO ORDERED, re (32 in 1:21-cv-01770-WCB, 38 in 1:21-cv-01429-WCB, 36 in 1:21-cv-01575-WCB) STIPULATION TO EXTEND TIME for various deadlines to the dates set forth in the stipulation filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc. Signed by Judge William C. Bryson on 07/01/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB(smg)
Jul 1, 2022 36 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for various deadlines to the dates set forth in the stipulation - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc.. (Wilson, Samantha)
Jun 6, 2022 35 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER, regarding STIPULATION TO EXTEND TIME for various deadlines to the dates set forth in the Stipulation. Signed by Judge William C. Bryson on 06/06/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB(smg)
Jun 3, 2022 34 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for various deadlines to the dates set forth in the Stipulation - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc.. (Wilson, Samantha)
May 27, 2022 33 Order on Motion to Appear Pro Hac Vice (5)
Docket Text: ORDER granting [32] Motion to Appear Pro Hac Vice. Signed by Judge William C. Bryson on 5/27/2022. (apk)
May 27, 2022 32 Motion for Leave to Appear Pro Hac Vice (5)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrew L. Hoffman - filed by Bayer Healthcare LLC. (Fahnestock, Derek)
May 20, 2022 31 Stipulation and Order (3)
Docket Text: STIPULATION AND ORDER to Extend Time. Signed by Judge William C. Bryson on 5/19/2022. Associated Cases: D.I. 32 in 1:21-cv-01429-WCB, D.I. 30 in 1:21-cv-01575-WCB, D.I. 28 in 1:21-cv-01770-WCB. (twk)
May 19, 2022 30 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME Various Deadlines (see Stipulation) to June 3, 2022 - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc.. (Wilson, Samantha)
May 13, 2022 29 Stipulation and Order (4)
Docket Text: STIPULATION AND ORDER to Extend Time. Signed by Judge William C. Bryson on 5/13/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB(cna, )
May 10, 2022 28 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for 1) Amneal to serve initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1); 2) for all parties to serve their initial disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI"); and 3) for all parties to submit a proposed Protective Order to May 20, 2022 - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals, Inc.. (Wilson, Samantha)
May 2, 2022 27 Notice of Service (8)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Identification of Asserted Patents and Accused Products and Methods filed by Bayer Healthcare LLC, Meda Pharmaceuticals Inc..(Fahnestock, Derek)
May 2, 2022 26 Notice (Other) (4)
Docket Text: NOTICE of Change of Address for Williams & Connolly LLP by Bayer Healthcare LLC, Meda Pharmaceuticals Inc. (Fahnestock, Derek)
Apr 26, 2022 25 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.)
Apr 26, 2022 24 Notice of Service (6)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures - filed by Bayer Healthcare LLC, Meda Pharmaceuticals Inc..(Fahnestock, Derek)
Apr 11, 2022 23 Scheduling Order (10)
Docket Text: SCHEDULING ORDER: Joinder of Parties due by 8/5/2022. Discovery due by 12/2/2022. Opening Expert Reports due by 1/13/2023. Rebuttal Expert Reports due by 3/3/2023. Dispositive Motions due by 5/26/2023. Claim Construction Opening Brief due by 8/26/2022. Claim Construction Answering Brief due by 9/9/2022. Claim Construction Reply Brief due by 9/16/2022. Claim Construction Surreply Brief due by 9/23/2022. A 5-day Bench Trial is set for 8/14/2023 at 09:00 AM in Courtroom 2A of the J. Caleb Boggs Federal Building and Courthouse in Wilmington, Delaware before Judge William C. Bryson. Signed by Judge William C. Bryson on 4/11/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB(nmg)
Apr 1, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Brandon M. White for Meda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Apr 1, 2022 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge William C. Bryson: Scheduling teleconference held on 4/1/2022. Counsel for all parties appeared. Court reporter present. The Court discussed the parties' proposals for various deadlines in the scheduling order. (Total Time in Court: 45 minutes) (Court reporter Ellie Corbett). Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB (nmg)
Mar 30, 2022 20 Main Document (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White - filed by Meda Pharmaceuticals Inc.. (Attachments: # (1) Certification of Brandon M. White)(Ward, Jennifer)
Mar 30, 2022 20 Certification of Brandon M. White (1)
Mar 30, 2022 21 Order on Motion to Appear Pro Hac Vice (4)
Docket Text: ORDER granting D.I. (20) MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White in case 1:21-cv-01429-WCB, D.I. (20) MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White in case 1:21-cv-01575-WCB, and D.I. (17) MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White in case 1:21-cv-01770-WCB. Signed by Judge William C. Bryson on 3/30/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB (nmg)
Mar 30, 2022 22 Letter to The Honorable William C. Bryson (1)
Mar 30, 2022 22 Main Document (11)
Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Bayer Healthcare LLC, Meda Pharmaceuticals Inc.. (Attachments: # (1) Letter to The Honorable William C. Bryson)(Smith, Rodger)
Mar 16, 2022 19 Order Setting Scheduling Conference (12)
Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 4/1/2022 at 10:00AM ET telephonically before Judge William C. Bryson. Shortly before the date for the conference, dial-in information will be provided by email to all counsel of record. In the interim, if counsel have questions regarding the scheduling conference or other matters, they can contact my law clerk, Mr. Dane Sowers, at sowersd@cafc.uscourts.gov. Signed by Judge William C. Bryson on 3/16/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB(nmg)
Mar 7, 2022 17 Motion for Leave to Appear Pro Hac Vice (7)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dov P. Grossman and Christopher J. Mandernach - filed by Bayer Healthcare LLC. (Fahnestock, Derek)
Mar 7, 2022 18 Order on Motion to Appear Pro Hac Vice (7)
Docket Text: ORDER granting Motion to Appear Pro Hac Vice for Dov P. Grossman and Christopher J. Mandernach. Signed by Judge William C. Bryson on 03/07/2022. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB(smg)
Mar 3, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. Associated Cases: 1:21-cv-01429-WCB, 1:21-cv-01575-WCB, 1:21-cv-01770-WCB (rjb)
Jan 14, 2022 16 Disclosure Statement (2)
Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.)
Jan 6, 2022 15 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.)
Jan 6, 2022 14 Answer to Complaint (23)
Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.)
Dec 16, 2021 13 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.)
Dec 16, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Michael P. Hogan for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Dec 16, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 12/16/21. (ntl)
Nov 29, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Timothy H. Kratz for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Nov 29, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 11/29/21. (ntl)
Nov 26, 2021 12 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.)
Nov 18, 2021 11 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Myer, R.)
Nov 11, 2021 10 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Bayer Healthcare LLC, Meda Pharmaceuticals Inc.: For Aurobindo Pharma USA, Inc. waiver sent on 11/10/2021, answer due 1/10/2022. (Fahnestock, Derek)
Nov 11, 2021 9 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Bayer Healthcare LLC, Meda Pharmaceuticals Inc.: For Aurobindo Pharma Ltd. waiver sent on 11/10/2021, answer due 1/10/2022. (Fahnestock, Derek)
Nov 10, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Nov 5, 2021 8 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Viatris Inc. for Meda Pharmaceuticals Inc. filed by Meda Pharmaceuticals Inc.. (Ward, Jennifer)
Nov 4, 2021 1 Main Document (19)
Docket Text: COMPLAINT filed against Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3736911.) - filed by Bayer Healthcare LLC and Meda Pharmaceuticals Inc. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(srs)
Nov 4, 2021 7 Summons Issued (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd.. (srs)
Nov 4, 2021 6 Summons Issued (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA, Inc. on 11/4/2021. (srs)
Nov 4, 2021 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Healthcare LLC filed by Bayer Healthcare LLC. (srs)
Nov 4, 2021 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,071,073 B2 ;8,518,919 B2 ;9,919,050 B2. (srs)
Nov 4, 2021 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 1, 2021. Date of Expiration of Patent: Patent No. 8,071,073 expires on June 4, 2028 and Patent Nos. 8,518,919 and 9,919,050 expire on November 22, 2025.Thirty Month Stay Deadline: 4/1/2024. (srs)
Nov 4, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs)
Nov 4, 2021 1 Civil Cover Sheet (1)
Nov 4, 2021 1 Exhibit A-C (161)
Nov 4, 2021 1 Complaint* (1)
Menu